Skip to main content
See every side of every news story
Published loading...Updated

Clinical Data on ST-001 nanoFenretinide™ to be presented at USCLC Annual Workshop 2026

Summary by PR Newswire
/PRNewswire/ -- SciTech Development Inc., a clinical-stage oncology company advancing ST-001 nanoFenretinide™, today announced that early-stage clinical data...

7 Articles

wpnews.comwpnews.com
+6 Reposted by 6 other sources
Center

Clinical Data on ST-001 nanoFenretinide™ to be presented at USCLC Annual Workshop 2026

Results Highlight Early Clinical Benefit, High Systemic Exposure, and Manageable Toxicity in Cutaneous T-Cell Lymphoma Patients

·West Point, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

PR Newswire broke the news in United States on Wednesday, March 25, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal